Purchase Order N6809522P0009
Award Date 2/11/22
Potential Completion Date 5/12/22
Potential Value $250K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the APTIMA SARS-CoV-2 ASSAY, a 250-test COVID-19 test kit. The contract has an ultimate completion date of February 18, 2022 and a ceiling value of $320,542.72. The contract is not set-aside. Gen-Probe has held numerous federal contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for infectious disease...
- This is a $319,600 firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for COVID-19 testing reagents and the APTIMA SARS-CoV-2 assay. The award does not have a set-aside designation. Gen-Probe has held numerous federal contracts, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases to defense and civilian agencies. This delivery order is part of a larger $15 million...
- This is a $158,550.00 Firm Fixed Price Delivery Order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The contract is for the provision of COVID-19 assays, with an ultimate completion date of January 15, 2021. Gen-Probe is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases. This award is not associated...
- This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
- This federal contract award is for COVID-19 REAGENTS and the APTIMA SARS-COV-2 ASSAY, awarded to Gen-Probe Incorporated, a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The $127,590.00 Firm Fixed Price contract was issued by the Defense Health Agency, a defense agency, on September 10, 2020, with a completion date of September 30, 2020. The contract was not set aside and is part...
- This is a federal contract award from the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, to provide COVID-19 testing reagents and the APTIMA SARS-CoV-2 ASSAY. The $127,100.00 fixed-price contract was awarded on August 7, 2020 with a completion date of September 6, 2020. It was not set aside for a specific business type. Gen-Probe Incorporated is a key supplier of molecular diagnostic products and services to various federal agencies, including the Department of...
- This is a delivery order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for COVID-19 reagents. The contract has a ceiling value of $330,600.00 and a completion date of September 30, 2020. The contract is a firm fixed price type and was not set aside for any particular business category. Gen-Probe Incorporated is a for-profit organization that specializes in molecular diagnostic testing systems, assays, and related products and...
- This is a delivery order contract awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the APTIMA COMBO 2 ASSAY (CT/GC). The firm-fixed-price contract has a ceiling value of $497,300.00 and a completion date of August 31, 2022. The contract is not set aside and was awarded on November 29, 2021. Gen-Probe, as a specialized supplier in molecular diagnostics, has held numerous contracts with defense and civilian agencies to provide infectious disease...